MARKET

QURE

QURE

Uniqure
NASDAQ
27.00
+0.55
+2.08%
Pre Market: 27.03 +0.03 +0.11% 09:26 06/09 EDT
OPEN
26.85
PREV CLOSE
26.45
HIGH
27.76
LOW
26.78
VOLUME
771
TURNOVER
0
52 WEEK HIGH
71.50
52 WEEK LOW
8.73
MARKET CAP
1.70B
P/E (TTM)
-7.6875
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QURE last week (0601-0605)?
Weekly Report · 1d ago
Acting FDA head vows to block political interference, Endpoint News says
TipRanks · 5d ago
Watching uniQure; Shares See A Spike In Volume, Endpoints News Reports "Acting FDA Commissioner Pledges To Prevent Political Interference In Rare Disease Meeting"
Benzinga · 5d ago
FDA issues draft guidance to help accelerated cell, gene therapies for patients
TipRanks · 06/02 14:03
A Look At uniQure (QURE) Valuation After Strong Recent Share Price Gains
Simply Wall St · 06/02 00:28
uniQure: Why A Shifting FDA Could Change Everything For AMT-130
Seeking Alpha · 06/01 15:14
Weekly Report: what happened at QURE last week (0525-0529)?
Weekly Report · 06/01 10:01
Replimune, Dell Technologies, NetApp And Other Big Stocks Moving Higher on Friday
Benzinga · 05/29 14:32
More
About QURE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

Webull offers Uniqure NV stock information, including NASDAQ: QURE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QURE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QURE stock methods without spending real money on the virtual paper trading platform.